Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer [NA]
This is a completed clinical trial evaluating injection methods for locating sentinel lymph nodes during lymphatic mapping and sentinel lymp…
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer [Phase 2]
The CETRA Phase 2 trial of neoadjuvant Caelyx (pegylated liposomal doxorubicin) and trastuzumab in HER2-positive breast cancer has been with…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 [Phase 3]
A Phase 3 clinical trial (IBCSG-1-98) evaluating cognitive and related psychosocial effects in postmenopausal women with breast cancer recei…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 [Phase 3]
Phase 3 trial IBCSG-1-98 evaluating bone density and bone loss in postmenopausal women with breast cancer receiving treatment has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 [Phase 3]
Phase 3 trial IBCSG-1-98 evaluating fingernail-based assessment of bone health in postmenopausal women with breast cancer on hormone therapy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer [Phase 2]
A Phase II trial evaluating gemcitabine plus oxaliplatin for triple-negative metastatic breast cancer was terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery [NA]
A completed clinical trial update describing an access delivery model designed to remove barriers to breast cancer care delivery.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
This completed clinical trial evaluates dose adaptation of capecitabine guided by mobile phone toxicity monitoring in patients with metastat…
-
CLINICAL_TRIALS research · 2012-07-25Clinical Trial Update: Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer [Phase 2, Phase 3]
A clinical trial update discussing the efficacy and safety of Abraxane (paclitaxel albumin-bound) in the TAC regimen as neoadjuvant chemothe…
-
CLINICAL_TRIALS withdrawal · 2012-07-24Clinical Trial Update: Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]
A Phase 2 trial evaluating oxaliplatin in women with advanced or metastatic breast cancer that has not responded to prior chemotherapy has b…
-
CLINICAL_TRIALS research · 2012-07-24Clinical Trial Update: Tesetaxel as First-line Therapy for Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update exploring tesetaxel as first-line therapy for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer [Phase 1]
A Phase 1 trial evaluating the combination of dehydroepiandrosterone (DHEA) and letrozole for metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients
A completed clinical trial update examining methods to detect and predict chemotherapy-induced cardiac toxicity in patients with breast canc…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer [NA]
Completed clinical trial investigating predictive biologic parameters of cutaneous hypersensitivity after brachytherapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer [Phase 3]
A Phase 3 trial evaluated adding Herceptin (trastuzumab) to standard chemotherapy in the neoadjuvant treatment of operable breast cancer. Th…
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer [Phase 3]
A Phase 3 trial evaluating fulvestrant (ICI 182780) in women with Stage I or Stage II primary breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy [Phase 2]
Phase 2 trial evaluating gefitinib for metastatic breast cancer that progressed after antiestrogen therapy and nonsteroidal aromatase inhibi…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer [Phase 2]
A phase 2 clinical trial compared pazopanib plus lapatinib versus lapatinib alone in inflammatory breast cancer; results were posted in July…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer [Phase 2]
This is a Phase II randomized trial comparing trastuzumab with ixabepilone versus trastuzumab with docetaxel in patients with metastatic bre…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial compared two regimens of liposomal doxorubicin in women with metastatic breast cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]
A Phase 2 trial evaluating R101933 in combination with chemotherapy for metastatic breast cancer that has not responded to prior chemotherap…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer [Phase 1]
A Phase 1 trial evaluating neoadjuvant chemotherapy given before surgery in women with breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer [Phase 2, Phase 3]
This clinical trial update notes the termination of a Phase 2/Phase 3 study comparing capecitabine (Xeloda) with vinorelbine in women with m…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer
A completed clinical trial evaluated whether BMI, leptin, the leptin/adiponectin ratio, and CA-15-3 can serve as reliable biomarkers for bre…
-
CLINICAL_TRIALS research · 2012-07-18Clinical Trial Update: Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer [Phase 3]
Phase 3 trial update comparing irinotecan/capecitabine versus capecitabine in HER2-negative metastatic breast cancer. Current status is unkn…